IO Trademark

Trademark Overview


On Tuesday, June 21, 2022, a trademark application was filed for IO with the United States Patent and Trademark Office. The USPTO has given the IO trademark a serial number of 79358304. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by invIOs GmbH. The IO trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapy

Chemical, biochemical and biotechnological preparations used in industry and science

Surgical, medical and veterinary apparatus and instruments; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class

Scientific and technological services, namely, research and design in the fields of oncology, immunology and cell therapy; scientific and technological analysis services in the field of research, development and diagnostics; industrial analysis of blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; industrial research services in the field of oncology, immunology and cell therapy; scientific and medical research in the field of cancer or diseases of the immune system; research and development in the field of oncology, immunology and cell therapy
io

General Information


Serial Number79358304
Word MarkIO
Filing DateTuesday, June 21, 2022
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7333993
Registration DateTuesday, March 26, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Description of MarkThe mark consists of two geometric shapes forming the letters I and O. The first letter "I" appears as a vertical elongated oval with rounded sides at the top and bottom, appearing in dark turquoise at the bottom and fading to medium turquoise toward the top. The second stylized "O" appears as an oblong geometric shape that consists of a solid smaller shaded circle that is made up of medium turquoise fading into green and orange at the tip of the circle, it is positioned over the "i" and appears to be the "dot" over the "i" the smaller circle is attached to a larger dark turquoise circular shape that encircles a white circle that borders a center solid dark turquoise circle, the color white represents background and is not intended to be claimed as part of the mark.
Goods and ServicesPharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapy
Pseudo MarkINVIOS
Indication of Colors claimedThe color(s) dark turquoise, medium turquoise, green and orange is/are claimed as a feature of the mark.
Goods and ServicesChemical, biochemical and biotechnological preparations used in industry and science
Goods and ServicesSurgical, medical and veterinary apparatus and instruments; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class
Goods and ServicesScientific and technological services, namely, research and design in the fields of oncology, immunology and cell therapy; scientific and technological analysis services in the field of research, development and diagnostics; industrial analysis of blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; industrial research services in the field of oncology, immunology and cell therapy; scientific and medical research in the field of cancer or diseases of the immune system; research and development in the field of oncology, immunology and cell therapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 27, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameinvIOs GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAT

Party NameinvIOs GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAT

Party NameinvIOs GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAT

Trademark Events


Event DateEvent Description
Thursday, December 22, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 31, 2022APPLICATION FILING RECEIPT MAILED
Friday, March 31, 2023ASSIGNED TO EXAMINER
Thursday, April 6, 2023NON-FINAL ACTION WRITTEN
Friday, April 7, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 5, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Saturday, October 14, 2023LIMITATION OF GOODS RECEIVED FROM IB
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 6, 2023LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Tuesday, November 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 20, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, January 8, 2024NOTIFICATION PROCESSED BY IB
Thursday, June 27, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB